now urging physicians NOT to use alpha blockers for the initial treatment of hypertension
The American College of Cardiology is now urging physicians NOT to use alpha blockers for the initial treatment of hypertension.
This warning applies to the alpha blockers Cardura (doxazosin)...Hytrin (terazosin)...or Minipress (prazosin).
This new recommendation is due to results from the large ALLHAT hypertension trial.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote